Recommendations for the management of hepatitis C virus infection among people who inject drugs

J Grebely, G Robaeys, P Bruggmann, A Aghemo… - International Journal of …, 2015 - Elsevier
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …

Urgent action to fight hepatitis C in people who inject drugs in Europe

JF Dillon, JV Lazarus, HA Razavi - Hepatology, Medicine and Policy, 2016 - Springer
Hepatitis C virus (HCV) infection is a leading cause of liver cirrhosis and liver cancer, is
curable in most people. Injecting drug use currently accounts for 80% of new HCV infections …

Disparities in uptake of direct‐acting antiviral therapy for hepatitis C among people who inject drugs in a Canadian setting

ME Socías, L Ti, E Wood, E Nosova, M Hull… - Liver …, 2019 - Wiley Online Library
Abstract Background & Aims Despite the high burden of hepatitis C virus (HCV) infection
among people who inject drugs (PWID), uptake of interferon‐based therapies has been …

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study

J Grebely, M Alavi, M Micallef, AJ Dunlop… - …, 2016 - Wiley Online Library
Aims To estimate adherence and response to therapy for chronic hepatitis C virus (HCV)
infection among people with a history of injecting drug use. A secondary aim was to identify …

Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting: The LiveRLife …

AD Marshall, M Micallef, A Erratt, J Telenta… - International Journal of …, 2015 - Elsevier
Background The aim of this study was to assess factors associated with baseline knowledge
of HCV and liver disease, acceptability of transient elastography (TE) assessment …

Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs

SB Høj, B Jacka, N Minoyan, AA Artenie… - International Journal of …, 2019 - Elsevier
As direct-acting antiviral (DAA) therapy costs fall and eligibility criteria are relaxed, people
who inject drugs (PWID) will increasingly become eligible for HCV treatment. Yet eligibility …

[HTML][HTML] Opioid users' willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder

CNE Tompkins, J Neale, J Strang - Journal of Substance Abuse Treatment, 2019 - Elsevier
Aims Prolonged-release implantable and depot injection formulations of buprenorphine are
very recent developments in the treatment of opioid use disorder. Such formulations remove …

The benefits of hepatitis C virus cure: every rose has thorns

D Salmon, MU Mondelli, M Maticic… - Journal of viral …, 2018 - Wiley Online Library
To examine mid‐term benefits on hepatic complications, extrahepatic clinical syndromes
and quality of life associated with HCV cure; to review the few safety issues linked to oral …

[HTML][HTML] Cognitive restructuring based on metaphor therapy to challenge the irrational beliefs of drug addicts undergoing buprenorphine treatment

S Komasi, M Saeidi, A Zakiei, MM Amiri… - International Journal of …, 2017 - brieflands.com
Background: The use of metaphors rather than direct suggestions of treatment can help to
weaken defense mechanisms against any functional changes and so cause an increase in …

Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era

H Valerio, A McAuley, H Innes, N Palmateer… - International Journal of …, 2018 - Elsevier
Background & aims Although people who inject drugs (PWID) are at greatest risk of hepatitis
C (HCV), treatment uptake in this population has historically been low. Highly effective direct …